Treatment response of HPV-positive and HPV-negative head and neck squamous cell carcinoma cell lines

Oral Oncology

Volumn 49, Issue 6, 2013, Pages 560-566

  Nagel, Remco ^a   Martens De Kemp, Sanne R ^a   Buijze, Marijke ^a   Jacobs, Gerbren ^a   Braakhuis, Boudewijn J M ^a   Brakenhoff, Ruud H ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cetuximab; Chemoradiation; Cisplatin; Head and neck cancer; HNSCC; Human papillomavirus; Prognosis

Indexed keywords

CETUXIMAB; CISPLATIN;

ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RESISTANCE; CARCINOMA CELL; CHEMOSENSITIVITY; CONTROLLED STUDY; DRUG EFFICACY; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; TREATMENT RESPONSE; TUMOR CELL LINE; VIRUS STRAIN; WART VIRUS;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; HEAD AND NECK NEOPLASMS; HUMANS; PAPILLOMAVIRIDAE; RADIATION TOLERANCE; RADIOTHERAPY;

EID: 84877018563     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2013.03.446     Document Type: Article

References (22)

1. F. Kamangar, G.M. Dores, and W.F. Anderson Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world J Clin Oncol 24 14 2006 2137 2150
2. C.R. Leemans, B.J. Braakhuis, and R.H. Brakenhoff The molecular biology of head and neck cancer Nat Rev Cancer 11 1 2011 9 22
3. P.S. Rosenberg, M.H. Greene, and B.P. Alter Cancer incidence in persons with Fanconi anemia Blood 101 3 2003 822 826
4. M.E. Poole, S.L. Sailer, J.G. Rosenman, J.E. Tepper, M.C. Weissler, and W.W. Shockley Chemoradiation for locally advanced squamous cell carcinoma of the head and neck for organ preservation and palliation Arch Otolaryngol Head Neck Surg 127 12 2001 1446 1450
5. I. Astsaturov, R.B. Cohen, and P. Harari EGFR-targeting monoclonal antibodies in head and neck cancer Curr Cancer Drug Targets 7 7 2007 650 665
6. K.K. Ang, J. Harris, R. Wheeler, R. Weber, D.I. Rosenthal, and P.F. Nguyen-Tan Human papillomavirus and survival of patients with oropharyngeal cancer N Engl J Med 363 1 2010 24 35
7. R. Nagel, L. Clijsters, and R. Agami The miRNA-192/194 cluster regulates the Period gene family and the circadian clock FEBS J 276 19 2009 5447 5455
8. C.J. Lin, J.R. Grandis, T.E. Carey, S.M. Gollin, T.L. Whiteside, and W.M. Koch Head and neck squamous cell carcinoma cell lines: established models and rationale for selection Head Neck 29 2 2007 163 188
9. M.A. Hermsen, H. Joenje, F. Arwert, M.J. Welters, B.J. Braakhuis, and M. Bagnay Centromeric breakage as a major cause of cytogenetic abnormalities in oral squamous cell carcinoma Genes Chromosomes Cancer 15 1 1996 1 9
10. H.J. van Zeeburg, P.J. Snijders, G. Pals, M.A. Hermsen, M.A. Rooimans, and G. Bagby Generation and molecular characterization of head and neck squamous cell lines of fanconi anemia patients Cancer Res 65 4 2005 1271 1276
11. S.J. Smeets, A.T. Hesselink, E.J. Speel, A. Haesevoets, P.J. Snijders, and M. Pawlita A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen Int J Cancer 121 11 2007 2465 2472
12. S.C. le, R. Nagel, and R. Agami Diverse ways to control p27Kip1 function: miRNAs come into play Cell Cycle 6 22 2007 2742 2749
13. L.A. Kachnic, L. Li, L. Fournier, and H. Willers Fanconi anemia pathway heterogeneity revealed by cisplatin and oxaliplatin treatments Cancer Lett 292 1 2010 Jun 1 73 79
14. L.A. Padilla, B.S. Leung, and L.F. Carson Evidence of an association between human papillomavirus and impaired chemotherapy-induced apoptosis in cervical cancer cells Gynecol Oncol 85 1 2002 Apr 59 66
15. A. Saxena, C. Yashar, D.D. Taylor, and C. Gercel-Taylor Cellular response to chemotherapy and radiation in cervical cancer Am J Obstet Gynecol 192 5 2005 May 1399 1403
16. H.S. Jung, O.C. Erkin, M.J. Kwon, S.H. Kim, J.I. Jung, and Y.K. Oh The synergistic therapeutic effect of cisplatin with Human papillomavirus E6/E7 short interfering RNA on cervical cancer cell lines in vitro and in vivo Int J Cancer 130 8 2012 Apr 15 1925 1936
17. L.N. Putral, M.J. Bywater, W. Gu, N.A. Saunders, B.G. Gabrielli, and G.R. Leggatt RNA interference against human papillomavirus oncogenes in cervical cancer cells results in increased sensitivity to cisplatin Mol Pharmacol 68 5 2005 Nov 1311 1319
18. Y. Zheng, J. Zhang, and Z. Rao Ribozyme targeting HPV16 E6E7 transcripts in cervical cancer cells suppresses cell growth and sensitizes cells to chemotherapy and radiotherapy Cancer Biol Ther 3 11 2004 Nov 1129 1134
19. W.C. Spanos, P. Nowicki, D.W. Lee, A. Hoover, B. Hostager, and A. Gupta Immune response during therapy with cisplatin or radiation for human papillomavirus-related head and neck cancer Arch Otolaryngol Head Neck Surg 135 11 2009 1137 1146
20. R. Williams, D.W. Lee, B.D. Elzey, M.E. Anderson, B.S. Hostager, and J.H. Lee Preclinical models of HPV+ and HPV- HNSCC in mice: an immune clearance of HPV+ HNSCC Head Neck 31 7 2009 911 918
21. F. Dayyani, C.J. Etzel, M. Liu, C.H. Ho, S.M. Lippman, and A.S. Tsao Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC) Head Neck Oncol 2 2010 15
22. N.C. Olthof, J.M. Straetmans, R. Snoeck, F.C. Ramaekers, B. Kremer, and E.J. Speel Next-generation treatment strategies for human papillomavirus-related head and neck squamous cell carcinoma: where do we go? Rev Med Virol 22 2 2012 88 105